Clinical Trials
24 trialsNCT06632327 2026-05-08
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT07472478 2026-03-16
GIVEN
Guangdong Provincial People's Hospital
Phase 2 Not yet recruiting
NCT07432802 2026-02-27
STRADOS
Aarhus University Hospital
Phase NA Not yet recruiting
NCT06918132 2026-02-24
N-PLANC
Mayo Clinic
Phase 2 Recruiting
NCT01753414 2025-01-06
POSTILV
Radiation Therapy Oncology Group
Phase 2 Unknown
NCT02428764 2024-12-10
Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma
Sun Yat-sen University
Phase 2 Withdrawn
NCT01553942 2024-11-20
Afatinib With CT and RT for EGFR-Mutant NSCLC
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT04945928 2024-05-24
Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC
Ruijin Hospital
Phase NA Active not recruiting
NCT00030771 2024-01-17
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients
Swiss Cancer Institute
Phase 3 Completed
NCT00979212 2022-06-15
Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
Radiation Therapy Oncology Group
Phase 2 Completed
NCT00687986 2022-03-17
ROSEL
Amsterdam UMC, location VUmc
Phase 3 Terminated
NCT01059188 2022-03-11
Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)
Swiss Cancer Institute
Phase 2 Completed
NCT04413656 2020-06-04
cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation Operation
Shanghai Chest Hospital
Phase NA Unknown
NCT00107172 2019-10-18
Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00003231 2019-05-15
Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer
Swiss Cancer Institute
Phase 2 Completed
NCT00281827 2017-12-28
Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT00226577 2017-03-23
Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT00003901 2017-02-16
Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00003317 2016-07-13
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00984997 2016-06-30
Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00003111 2013-07-25
Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
Yale University
Phase 2 Completed
NCT00002642 2012-10-08
SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer
SWOG Cancer Research Network
Phase 2 Completed
NCT00563160 2010-07-07
Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery
Hospital Authority, Hong Kong
Phase 2 Unknown
NCT00098917 2008-01-28
Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1 Terminated